To compare vortioxetine and escitalopram in the management of major depressive disorder.
Phase 4
- Registration Number
- CTRI/2023/12/060774
- Lead Sponsor
- Dr Suravi Das
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
18-45 years of male and female, diagnosed as case of major depressive disorder, not been treated for the index episode.
Exclusion Criteria
Subjects with comorbid psychiatric disorder except for the comorbid anxiety symptoms and tobacco use, known case of diabetes or hypertension or dyslipidemia or hyperthyroidism, hypothyroidism, with medical or surgical condition that affect his or her locomotor capabilities, pregnancy and lactating female.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method